MedWatch - Stabilet Infant Warmers[Draeger]: Nationwide recall due to potential risk of fire and burns for patient and caregiver

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

 



Title: MedWatch - Stabilet Infant Warmers[Draeger]: Nationwide recall due to potential risk of fire and burns for patient and caregiver
MedWatch logo MedWatch - The FDA Safety Information and Adverse Event Reporting Program

Stabilet Infant Warmer models 200, 300, 1250, 1500, 200/3000, 2000, 2200/3200, 3000, and 3200 [Draeger/Hill-Rom]

Audience: Pediatric and Obstetric Healthcare professionals, hospital risk managers

Draeger Medical and FDA notified healthcare professionals that it recommends the removal of Stabilet Infant Warmer models 200, 300, 1250, 1500, 200/3000, 2000, 2200/3200, 3000, and 3200 from service as soon as possible due to concern that continued use of these devices may result in serious injury to the patient and/or caregiver.  A January 2008 fire in a Minnesota neonatal unit injured an infant and an independent investigation concluded that the Hill-Rom Stabilet 1250 was likely the ignition source of the fire.  Draeger agrees with the recommendation to remove the referenced Stabilet models from service immediately.  Immediate actions required include:

  • Locate and identify the devices listed in this notice.
  • Remove the referenced devices from service as soon as possible.
  • If an infant is currently receiving therapy from one of the referenced devices, consider the risk of moving the patient before changing to an alternative mode of therapy.
  • Once removed from service, the warmers should be rendered unusable by removing the heating element and the power cord. These warmers should not be used or sold for any other purpose.

A recall notification is being sent out to all known current users and is available in the Draeger website at www.draeger.com/Stabilet.   Health care professionals and consumers should report serious adverse events (side effects) or product quality problems with the use of this product to Draeger Medical Systems Inc. or to the FDA MedWatch Adverse Event reporting Program, www.fda.gov/medwatch/report.htm.

Read the complete MedWatch 2009 Safety summary, including a link to the updated firm press release, at:

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm173239.htm

 


You are encouraged to report all serious adverse events and product quality problems to FDA MedWatch at www.fda.gov/medwatch/report.htm

Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@xxxxxxxxxxxxxxx.

This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

FDA HHS

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420


[Index of Archives]     [CDC News]     [NIH News]     [USDA News]     [Steve's Art]     [Camping in Yosemite]     [PhotoForum]     [SB Lupus]     [STB]

  Powered by Linux